Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin- ARFIM Study

NCT03960021 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT03960021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03960021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin- ARFIM Study
Lead sponsor
Institut Bergonié
Phase
Not applicable
Overall status
Terminated
Start date
March 4, 2019
Completion date
March 15, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cell, colo-rectal cancer, immune evasion, tumor, neoplastic cells, circulating, pulmonary metastasis